| Secondary |
| Hypertension |
30.3% |
| Product Used For Unknown Indication |
19.9% |
| Drug Use For Unknown Indication |
13.9% |
| Hypercholesterolaemia |
6.0% |
| Essential Hypertension |
5.1% |
| Depression |
2.7% |
| Urinary Tract Infection |
2.7% |
| Diabetes Mellitus |
2.2% |
| Neuralgia |
2.2% |
| Pain |
2.2% |
| Oligodendroglioma |
2.0% |
| Renal Hypertension |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Secondary Hypertension |
1.3% |
| Atrial Fibrillation |
1.1% |
| Endocarditis |
1.1% |
| Back Pain |
0.9% |
| Cardiac Failure |
0.9% |
| Endocrine Hypertension |
0.9% |
| Epilepsy |
0.9% |
|
| Renal Failure Acute |
9.3% |
| Toxic Skin Eruption |
9.3% |
| Hyponatraemia |
7.0% |
| Liver Injury |
7.0% |
| Interstitial Lung Disease |
5.8% |
| Leukocytoclastic Vasculitis |
5.8% |
| Malaise |
5.8% |
| Somnambulism |
5.8% |
| Umbilical Cord Abnormality |
5.8% |
| Orthostatic Hypotension |
4.7% |
| Pancytopenia |
4.7% |
| Headache |
3.5% |
| Neuropathy Peripheral |
3.5% |
| Rash Macular |
3.5% |
| Tachycardia |
3.5% |
| Viith Nerve Paralysis |
3.5% |
| Vomiting |
3.5% |
| Wrong Drug Administered |
3.5% |
| Back Pain |
2.3% |
| Fall |
2.3% |
|
| Concomitant |
| Hypertension |
22.6% |
| Product Used For Unknown Indication |
20.5% |
| Drug Use For Unknown Indication |
20.0% |
| Rheumatoid Arthritis |
4.7% |
| Diabetes Mellitus |
4.0% |
| Hypercholesterolaemia |
3.2% |
| Atrial Fibrillation |
3.1% |
| Non-small Cell Lung Cancer |
2.6% |
| Osteoporosis |
2.2% |
| Pain |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Prophylaxis |
2.0% |
| Depression |
1.9% |
| Hyperparathyroidism |
1.7% |
| Breast Cancer |
1.5% |
| Blood Pressure |
1.2% |
| Prostate Cancer |
1.1% |
| Anxiety |
1.1% |
| Asthma |
1.0% |
| Cardiomyopathy |
1.0% |
|
| Vomiting |
14.2% |
| Renal Failure |
8.6% |
| Pulmonary Embolism |
7.3% |
| Renal Failure Acute |
6.9% |
| Thrombocytopenia |
6.5% |
| Hypertension |
4.7% |
| Somnolence |
4.7% |
| Hyponatraemia |
4.3% |
| Oedema Peripheral |
4.3% |
| Death |
3.9% |
| Nausea |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Weight Decreased |
3.9% |
| Rhabdomyolysis |
3.4% |
| Sensory Loss |
3.4% |
| Sepsis |
3.4% |
| Tachycardia |
3.4% |
| Loss Of Consciousness |
3.0% |
| Myalgia |
3.0% |
| Pain In Extremity |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
55.0% |
| Hypertension |
30.0% |
| Bronchopulmonary Aspergillosis Allergic |
5.0% |
| Chest Pain |
2.5% |
| Hypothyroidism |
2.5% |
| Pain |
2.5% |
| Pruritus Generalised |
2.5% |
|
| Visual Acuity Reduced |
42.9% |
| Tachycardia |
28.6% |
| Fall |
14.3% |
| Malaise |
14.3% |
|
